{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T06:35:39Z","timestamp":1781850939752,"version":"3.54.5"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.rmed.2021.106697","type":"journal-article","created":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T20:41:32Z","timestamp":1637786492000},"page":"106697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Pulmonary histopathology of interstitial lung disease associated with antisynthetase antibodies"],"prefix":"10.1016","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6186-5732","authenticated-orcid":false,"given":"Bess M.","family":"Flashner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7234-5652","authenticated-orcid":false,"given":"Paul A.","family":"VanderLaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Nurhussien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary B.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Hallowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2021.106697_bib1","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/BOR.0b013e3282f01a8c","article-title":"Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance","volume":"19","author":"Mimori","year":"2007","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.rmed.2021.106697_bib2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2169\/internalmedicine.49.2889","article-title":"Clinical and pathological findings of interstitial lung disease patients with anti-aminoacyl-tRNA synthetase autoantibodies","volume":"49","author":"Koreeda","year":"2010","journal-title":"Int. Med."},{"key":"10.1016\/j.rmed.2021.106697_bib3","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/00002281-200011000-00005","article-title":"Interstitial lung disease in polymyositis and dermatomyositis","volume":"12","author":"Hirakata","year":"2000","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.rmed.2021.106697_bib4","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.rmed.2014.09.003","article-title":"Clinical and pathologic differences in interstitial lung disease based on antisynthetase antibody type","volume":"108","author":"Johnson","year":"2014","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2021.106697_bib5","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.rmed.2011.03.022","article-title":"Detection of antisynthetase syndrome in patients with idiopathic interstitial pneumonias","volume":"105","author":"Watanabe","year":"2011","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2021.106697_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120313","article-title":"Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis\/dermatomyositis-associated interstitial lung disease: a retrospective case control study","volume":"10","author":"Hozumi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.rmed.2021.106697_bib7","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1002\/art.30513","article-title":"Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients","volume":"63","author":"Marie","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.rmed.2021.106697_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-023998","article-title":"Systematic review and meta-analysis of prognostic factors for idiopathic inflammatory myopathy-associated interstitial lung disease","volume":"8","author":"Kamiya","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.rmed.2021.106697_bib9","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3899\/jrheum.181141","article-title":"Evolution of pulmonary function in a cohort of patients with interstitial lung disease and positive for antisynthetase antibodies","volume":"47","author":"Gonz\u00e1lez-P\u00e9rez","year":"2020","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.rmed.2021.106697_bib10","doi-asserted-by":"crossref","first-page":"1583516","DOI":"10.1080\/20018525.2019.1583516","article-title":"Clinical characteristics and outcome in patients with antisynthetase syndrome associated interstitial lung disease: a retrospective cohort study","volume":"6","author":"Jensen","year":"2019","journal-title":"Eur. Clin. Respir. J."},{"key":"10.1016\/j.rmed.2021.106697_bib11","doi-asserted-by":"crossref","first-page":"60442","DOI":"10.1371\/journal.pone.0060442","article-title":"Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome","volume":"8","author":"Hamaguchi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.rmed.2021.106697_bib12","article-title":"Interstitial lung disease in patients with antisynthetase syndrome: a retrospective case series study","author":"Baratella","year":"2020","journal-title":"Jpn. J. Radiol."},{"key":"10.1016\/j.rmed.2021.106697_bib13","doi-asserted-by":"crossref","first-page":"5349","DOI":"10.1007\/s00330-019-06152-5","article-title":"Prognostic factors of interstitial lung disease progression at sequential HRCT in anti-synthetase syndrome","volume":"29","author":"Liu","year":"2019","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.rmed.2021.106697_bib14","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.resinv.2019.03.002","article-title":"Diagnostic utility of transbronchial lung cryobiopsy: two cases of anti-aminoacyl-tRNA synthetase syndrome with respiratory failure","volume":"57","author":"Yoshimura","year":"2019","journal-title":"Respir. Invest."},{"key":"10.1016\/j.rmed.2021.106697_bib15","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1164\/rccm.201508-1632OC","article-title":"In-hospital mortality after surgical lung biopsy for interstitial lung disease in the United States. 2000 to 2011","volume":"193","author":"Hutchinson","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2021.106697_bib16","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.jtcvs.2013.09.050","article-title":"Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer","volume":"147","author":"Sato","year":"2014","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.rmed.2021.106697_bib17","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.humpath.2014.01.018","article-title":"The pulmonary histopathologic manifestations of the anti-PL7\/antithreonyl transfer RNA synthetase syndrome","volume":"45","author":"Yousem","year":"2014","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.rmed.2021.106697_bib18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.5858\/arpa.2017-0010-OA","article-title":"Pulmonary pathologic manifestations of anti-alanyl-tRNA synthetase (anti-PL-12)-related inflammatory myopathy","volume":"142","author":"Schneider","year":"2018","journal-title":"Arch. Pathol. Lab Med."},{"key":"10.1016\/j.rmed.2021.106697_bib19","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/art.24631","article-title":"Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease","volume":"60","author":"Richards","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.rmed.2021.106697_bib20","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1164\/ajrccm\/141.3.727","article-title":"Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings","volume":"141","author":"Tazelaar","year":"1990","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.rmed.2021.106697_bib23","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1164\/ajrccm.165.2.ats01","article-title":"American thoracic society\/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias","volume":"165","author":"Travis","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2021.106697_bib24","series-title":"Practical Pulmonary Pathology: A Diagnostic Approach","author":"Leslie","year":"2018"},{"key":"10.1016\/j.rmed.2021.106697_bib25","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1128\/cdli.4.2.236-240.1997","article-title":"Inflammatory myopathy, bronchiolitis obliterans\/organizing pneumonia, and anti-Jo-1 antibodies - an interesting association","volume":"4","author":"Kalenian","year":"1997","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.rmed.2021.106697_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-217624","article-title":"Antisynthetase syndrome (ASS) presenting as acute respiratory distress syndrome (ARDS) in a patient without myositis features","volume":"2016","author":"Kanchustambham","year":"2016","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.rmed.2021.106697_bib27","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.1378\/chest.14-2402","article-title":"A 43-year-old man with antisynthetase syndrome presenting with acute worsening of dyspnea","volume":"147","author":"Kulkarni","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2021.106697_bib28","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/acr.21895","article-title":"Interstitial lung disease in anti-Jo-1 patients with antisynthetase syndrome","volume":"65","author":"Marie","year":"2013","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.rmed.2021.106697_bib29","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.2169\/internalmedicine.2454-18","article-title":"Anti-jo-1 antibody-positive interstitial pneumonia in an elderly patient with congenital rubella syndrome","volume":"58","author":"Nozue","year":"2019","journal-title":"Int. Med."},{"key":"10.1016\/j.rmed.2021.106697_bib30","doi-asserted-by":"crossref","first-page":"376","DOI":"10.5606\/ArchRheumatol.2018.6577","article-title":"Histological findings of organizing pneumonia, based on transbronchial lung biopsy, may predict poor outcome in polymyositis and dermatomyositis: report of two autopsied cases","volume":"33","author":"Oiwa","year":"2018","journal-title":"Arch. Rheumatol."},{"key":"10.1016\/j.rmed.2021.106697_bib31","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3109\/s10165-004-0328-z","article-title":"A case of polymyositis complicated with organizing pneumonia: case report and literature review","volume":"14","author":"Oiwa","year":"2004","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.rmed.2021.106697_bib32","doi-asserted-by":"crossref","first-page":"231006","DOI":"10.1136\/bcr-2019-231006","article-title":"Jo1-antisynthetase syndrome and severe interstitial lung disease with organising pneumonia on histopathology with favourable outcome on early combined treatment with corticosteroids, mycophenolate mofetil and rituximab Rare disease","volume":"12","author":"R\u00fcegg","year":"2019","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.rmed.2021.106697_bib33","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1183\/09031936.97.10122907","article-title":"Pulmonary fibrosis with predominant CD8 lymphocytic alveolitis and anti-Jo-1 antibodies","volume":"10","author":"Sauty","year":"1997","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2021.106697_bib34","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1513\/AnnalsATS.202002-126RL","article-title":"Recurrent pulmonary fibrosis in a lung allograft secondary to de novo antisynthetase syndrome","volume":"17","author":"Scallan","year":"2020","journal-title":"Ann. Am.Thorac. Soc."},{"key":"10.1016\/j.rmed.2021.106697_bib35","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3109\/03009742.2011.566280","article-title":"Long-term outcome of lung transplantation in a patient with the anti-synthetase syndrome","volume":"40","author":"Sem","year":"2011","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.rmed.2021.106697_bib36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/thx.2006.069237","article-title":"Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset","volume":"63","author":"Tillie-Leblond","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2021.106697_bib37","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s10067-013-2207-5","article-title":"Antisynthetase antibody syndrome: case report and review of the literature","volume":"32","author":"Uribe","year":"2013","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.rmed.2021.106697_bib38","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00124743-199908000-00008","article-title":"Bronchiolitis obliterans with organizing pneumonia (BOOP) heralding anti-Jo-1-positive polymyositis","volume":"5","author":"Xing","year":"1999","journal-title":"J. Clin. Rheumatol."},{"key":"10.1016\/j.rmed.2021.106697_bib39","doi-asserted-by":"crossref","first-page":"5924","DOI":"10.21037\/jtd.2018.09.42","article-title":"Interstitial lung disease associated with anti-citrullinated peptide\/protein antibody-positive anti-synthetase syndrome","volume":"10","author":"Yamakawa","year":"2018","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.rmed.2021.106697_bib40","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/rheumatology\/kel112","article-title":"Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis\/dermatomyositis","volume":"46","author":"Yamasaki","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.rmed.2021.106697_bib41","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/modpathol.2010.65","article-title":"The pulmonary histopathologic manifestations of the anti-Jo-1 tRNA synthetase syndrome","volume":"23","author":"Yousem","year":"2010","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.rmed.2021.106697_bib42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.rmed.2016.07.009","article-title":"Clinical features and outcomes of interstitial lung disease in anti-Jo-1 positive antisynthetase syndrome","volume":"118","author":"Zamora","year":"2016","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2021.106697_bib43","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1111\/imj.14653","article-title":"Bilateral lung transplantation in antisynthetase syndrome","volume":"49","author":"Brown","year":"2019","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.rmed.2021.106697_bib44","doi-asserted-by":"crossref","first-page":"243","DOI":"10.5603\/ARM.2019.0041","article-title":"An unusual case of idiopathic inflammatory myopathy presenting with organizing pneumonia as cavitary lesions","volume":"87","author":"Agrawal","year":"2019","journal-title":"Adv. Respir. Med."},{"key":"10.1016\/j.rmed.2021.106697_bib45","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/0954-6111(95)90237-6","article-title":"Anti-Jo-1 Syndrome presenting as cryptogenic organizing pneumonia","volume":"89","author":"Chan","year":"1995","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2021.106697_bib46","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.resinv.2016.02.005","article-title":"A case of non-specific interstitial pneumonia with recurrent gastric carcinoma and anti-Jo-1 antibody positive myositis","volume":"54","author":"Ebisutani","year":"2016","journal-title":"Respir. Invest."},{"key":"10.1016\/j.rmed.2021.106697_bib47","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0049-0172(96)80026-6","article-title":"Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis","volume":"26","author":"Friedman","year":"1996","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.rmed.2021.106697_bib48","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1183\/09031936.00014707","article-title":"Acute respiratory distress syndrome secondary to antisynthetase syndrome is reversible with tacrolimus","volume":"31","author":"Guglielmi","year":"2008","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2021.106697_bib49","first-page":"13","article-title":"Anti-synthetase syndrome presenting as cryptogenic organizing pneumonia","volume":"6","author":"Haydour","year":"2012","journal-title":"Respir. Med. Case Rep."},{"key":"10.1016\/j.rmed.2021.106697_bib50","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1067\/S0190-9622(03)01482-8","article-title":"Fatal interstitial pulmonary fibrosis in anti-Jo-1-negative amyopathic dermatomyositis","volume":"49","author":"High","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.rmed.2021.106697_bib51","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2169\/internalmedicine.44.319","article-title":"Long-term clinical course of a patient with anti PL-12 antibody accompanied by interstitial pneumonia and severe pulmonary hypertension","volume":"44","author":"Handa","year":"2005","journal-title":"Int. Med."},{"key":"10.1016\/j.rmed.2021.106697_bib52","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/rheumatology\/kep455","article-title":"Clinical manifestations of anti-synthetase syndrome positive for anti-alanyl-tRNA synthetase (anti-PL12) antibodies: a retrospective study of 17 cases","volume":"49","author":"Hervier","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.rmed.2021.106697_bib53","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1378\/chest.08-2233","article-title":"Clinical profile of anti-PL-12 autoantibody: cohort study and review of the literature","volume":"135","author":"Kalluri","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2021.106697_bib54","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/1756-185X.12058","article-title":"Pulmonary capillaritis in a patient with moderately positive anti-PL-12 antibodies","volume":"16","author":"Kummerfeldt","year":"2013","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.rmed.2021.106697_bib55","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0002-9343(90)90149-8","article-title":"Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase)","volume":"88","author":"Targoff","year":"1990","journal-title":"Am. J. Med."},{"key":"10.1016\/j.rmed.2021.106697_bib56","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.2169\/internalmedicine.45.1772","article-title":"Antisynthetase syndrome associated with sarcoidosis","volume":"45","author":"Asanuma","year":"2006","journal-title":"Int. Med."},{"key":"10.1016\/j.rmed.2021.106697_bib57","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.aller.2014.04.005","article-title":"Anti-PL7 antisynthetase syndrome: a rare cause of autoimmune-mediated interstitial lung disease","volume":"43","author":"de la Varga","year":"2015","journal-title":"Allergol. Immunopathol."},{"key":"10.1016\/j.rmed.2021.106697_bib58","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1183\/09031936.00104310","article-title":"Antisynthetase syndrome positive for anti-threonyl-tRNA synthetase (anti-PL7) antibodies","volume":"37","author":"Hervier","year":"2011","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2021.106697_bib59","first-page":"206","article-title":"Anti-PL-7 (Anti-Threonyl-tRNA synthetase) Antisynthetase syndrome: clinical manifestations in a series of patients from a european multicenter study (EUMYONET) and review of the literature","volume":"91","author":"Labirua-Iturburu","year":"2012","journal-title":"Med (United States)"},{"key":"10.1016\/j.rmed.2021.106697_bib60","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ejim.2013.01.002","article-title":"Clinical manifestations and outcome of anti-PL7 positive patients with antisynthetase syndrome","volume":"24","author":"Marie","year":"2013","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.rmed.2021.106697_bib61","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.resinv.2016.01.005","article-title":"Severe respiratory failure as a presenting feature of an interstitial lung disease associated with anti-synthetase syndrome (ASS)","volume":"54","author":"Piroddi","year":"2016","journal-title":"Respir. Invest."},{"key":"10.1016\/j.rmed.2021.106697_bib62","first-page":"1318","article-title":"Rituximab in autoimmune connective tissue disease-associated interstitial lung disease","volume":"55","author":"Sharp","year":"2016","journal-title":"Rheumatol (United Kingdom)"},{"key":"10.1016\/j.rmed.2021.106697_bib63","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.resinv.2019.12.003","article-title":"Clinical, radiological, and pathological features of anti-asparaginyl tRNA synthetase antibody-related interstitial lung disease","volume":"58","author":"Aiko","year":"2020","journal-title":"Respir. Invest."},{"key":"10.1016\/j.rmed.2021.106697_bib64","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/art.22506","article-title":"Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase","volume":"56","author":"Hirakata","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.rmed.2021.106697_bib65","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.4049\/jimmunol.162.4.2315","article-title":"Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease","volume":"162","author":"Hirakata","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.rmed.2021.106697_bib66","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2169\/internalmedicine.48.2207","article-title":"Nonspecific interstitial pneumonia (NSIP) associated with anti-KS antibody: differentiation from idiopathic NSIP","volume":"48","author":"Okayasu","year":"2009","journal-title":"Int. Med."},{"key":"10.1016\/j.rmed.2021.106697_bib67","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5858\/arpa.2013-0667-OA","article-title":"The pulmonary histopathology of anti-KS transfer RNA synthetase syndrome","volume":"139","author":"Schneider","year":"2015","journal-title":"Arch. Pathol. Lab Med."},{"key":"10.1016\/j.rmed.2021.106697_bib68","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1007\/s10067-016-3258-1","article-title":"Heterogeneous clinical spectrum of interstitial lung disease in patients with anti-EJ anti-synthetase syndrome: a case series","volume":"35","author":"Giannini","year":"2016","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.rmed.2021.106697_bib69","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/pin.12140","article-title":"Anti-glycyl tRNA synthetase antibody associated interstitial lung disease without symptoms of polymyositis\/dermatomyositis","volume":"64","author":"Hara","year":"2014","journal-title":"Pathol. Int."},{"key":"10.1016\/j.rmed.2021.106697_bib70","doi-asserted-by":"crossref","first-page":"448","DOI":"10.12659\/AJCR.903540","article-title":"A rare case of necrotizing myopathy and fibrinous and organizing pneumonia with anti-EJ antisynthetase syndrome and sj\u00f6gren\u2019s syndrome (SSA) antibodies","volume":"18","author":"Kashif","year":"2017","journal-title":"Am. J. Case Rep."},{"key":"10.1016\/j.rmed.2021.106697_bib71","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12890-016-0325-y","article-title":"Long-term clinical course of anti-glycyl tRNA synthetase (anti-EJ) antibody-related interstitial lung disease pathologically proven by surgical lung biopsy","volume":"16","author":"Sasano","year":"2016","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.rmed.2021.106697_bib72","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/his.12420","article-title":"Expanding the spectrum of pulmonary histopathological manifestations of anti-synthetase syndrome: anti-EJ-associated acute fibrinous and organizing pneumonia","volume":"65","author":"Sauter","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.rmed.2021.106697_bib73","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1136\/jclinpath-2014-202367","article-title":"Pulmonary pathologic manifestations of anti-glycyl-tRNA synthetase (anti-EJ)-related inflammatory myopathy","volume":"67","author":"Schneider","year":"2014","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.rmed.2021.106697_bib74","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.resinv.2012.04.003","article-title":"A case of interstitial lung disease with anti-EJ and anti-CCP antibodies preceding rheumatoid arthritis","volume":"50","author":"Tomioka","year":"2012","journal-title":"Respir. Invest."},{"key":"10.1016\/j.rmed.2021.106697_bib75","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/rheumatology\/kel435","article-title":"Clinical characteristics of Japanese patients with anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibodies","volume":"46","author":"Sato","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.rmed.2021.106697_bib76","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2559.2004.01926.x","article-title":"The spectrum of pathological changes in severe acute respiratory syndrome (SARS)","volume":"45","author":"Cheung","year":"2004","journal-title":"Histopathology"},{"key":"10.1016\/j.rmed.2021.106697_bib77","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pupt.2015.12.004","article-title":"Benefit of adjunctive tacrolimus in connective tissue disease-interstitial lung disease","volume":"36","author":"Witt","year":"2016","journal-title":"Pulm. Pharmacol. Therapeut."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611121004054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611121004054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T12:22:37Z","timestamp":1760617357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611121004054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":75,"alternative-id":["S0954611121004054"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2021.106697","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary histopathology of interstitial lung disease associated with antisynthetase antibodies","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2021.106697","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106697"}}